Press release
Global Branded Generics Market Competitive Strategies and Worldwide Demand with Top players- Teva Pharmaceutical Industries Ltd.; Zydus Cadila; Hetero; AstraZeneca; Mylan N.V
Global Branded Generics Market
Market Analysis:
Global Branded Generics Market is expected to rise from its initial estimated value of USD 232.83 billion in 2018 to a projected value of USD 421.15 billion by 2026, registering a CAGR of 7.69% in the forecast period of 2019-2026. This rise in market value can be attributed to growing need for cheaper treatment options and pharmaceutical drugs required by patients.
Get Sample Report + All Related Graphs & Charts @
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-branded-generics-market
Key Market Competitors:
Teva Pharmaceutical Industries Ltd.; Zydus Cadila; Hetero; AstraZeneca; Mylan N.V.; Novartis AG; Pfizer Inc.; GlaxoSmithKline plc; Aspen Holdings; Bausch Health; Eris Lifesciences Limited; Par Pharmaceutical; Sanofi; Apotex Inc.; Dr. Reddy's Laboratories Ltd.; Abbott; Sun Pharmaceutical Industries Ltd.; Lupin Pharmaceuticals, Inc.; ALLERGAN; Stada Arzneimittel; Cipla Inc. and EVA PHARMA are few of the major competitors currently working in the branded generics market.
Global Branded Generics Market By Product Type (Value-Added Branded Generics, Trade Named Generics), Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics & Anti-Inflammatory, Others), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptic, Others), Consumption Type (Oral, Parenteral, Topical, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends & Forecast to 2026
Market Definition: Global Branded Generics Market
Branded generic can be defined as those pharmaceutical drugs that have been re-released with a different brand name. These drugs are produced by various pharmaceutical manufacturing companies as the patent of this drug has already expired and the generic drugs are sold at a lower cost. Even though, there isn't any difference in the quality or manufacturing process of the drug.
Market Drivers:
Growth in the number of patents expired and expiring for the branded drugs; this factor is one of the major factors driving the market growth
Growth in the incidents and population suffering from chronic diseases and disorders; this factor is expected to drive the market growth
Market Restraint:
Lack of penetration associated with the number of generic drugs worldwide; this factor is expected to act as a restraint to the market growth
Grab Your Report at an Impressive 30% Discount! Please click Here@
https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-branded-generics-market
Segmentation: Global Branded Generics Market
By Product Type
Value-Added Branded Generics
Trade (Brand) Named Generics
By Therapeutic Application
Oncology
Cardiovascular Diseases
Diabetes
Neurology
Gastrointestinal Diseases
Dermatology Diseases
Analgesics & Anti-Inflammatory
Others
By Drug Class
Alkylating Agents
Antimetabolites
Hormones
Anti-Hypertensive
Lipid Lowering Drugs
Anti-Depressants
Anti-Psychotics
Anti-Epileptic
Others
By Consumption Type
Oral
Parenteral
Topical
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Key Developments in the Market:
In January 2019, Hetero announced the launch of generic version of "lapatinib" in India, which will be commercialized as "Hertab" by Hetero Healthcare Ltd.
In February 2018, Hetero announced the launch of a generic fixed-dose combination (FDC) drug of "emtricitabine" and "tenofovir alafenamide" in India. The product has already been approved by Drug Controller General of India (DCGI) will be commercialized as "Tafero-EM" by Hetero Healthcare Ltd.
In November 2017, Eris Lifesciences Limited announced that they had agreed to acquire the branded generics division of Strides Shasun Limited. This acquisition will help in establishing Eris Lifesciences Limited as one of the top ten companies worldwide for Central Nervous System treatment segment.
Reasons to Purchase this Report
Current and future of global branded generics market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Note: If you have any special requirements, please let us know and we will offer you the report as you want.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:?Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Branded Generics Market Competitive Strategies and Worldwide Demand with Top players- Teva Pharmaceutical Industries Ltd.; Zydus Cadila; Hetero; AstraZeneca; Mylan N.V here
News-ID: 2047796 • Views: …
More Releases from Data Bridge Market Research
Anthrax Treatment Market CAGR of 6.6% by 2029, Size, Share, Trends, Growth Oppor …
Global Anthrax Treatment Market report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. This marketing report offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. Anthrax Treatment market is supposed to grow during the forecast period due to growing demand…
Pneumococcal Vaccine Market CAGR of 5.5% by 2029, Size, Share, Trends, Growth Op …
Pneumococcal Vaccine Market survey report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. Furthermore, big sample sizes have been utilized for the data collection in this business report which suits the necessities of small, medium as well as large size of businesses. The report explains the moves of top market players and…
Nano Bioreactor Market to Observe Highest Growth of USD 6.3 billion with an Exce …
Global Nano Bioreactor Market study by Data Bridge Market Research provides details about the market dynamics affecting this market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years.
The latest market data has been presented in the Nano Bioreactor market study on the revenue numbers, product details, and sales of the major firms. In addition to this,…
Shock Sensor Market to Observe Highest Growth of USD 10,251,664.71 thousand with …
A Qualitative Research Study accomplished by Data Bridge Market research's database of 350 pages, titled as Global Shock Sensor Market with 100+ market data Tables, Pie Charts, Graphs & Figures spread through Pages and easy to understand detailed analysis. The rapidly revolutionizing market place demands the best market and business solutions to thrive in the market.
Shock Sensor Market business report can be referred efficiently by both established and new players…
More Releases for Generics
Japan Generics Drug Market Outlook 2020 Report
“Japan Generics Drug Market Outlook 2020” Report Highlights:
* Introduction to Japanese Generic Drug Market
* Attractiveness of Japanese Generic Market
* Super Generics in Japan
* Japan Healthcare System & Generic Drugs
* Different Parameters for Generic & Branded Drugs
* Comparison of Generic Drugs in US & Japan
* Japan Generics Drug Market Analysis
* Japan Generics Drug Market Future Prospects
Download Report Sample Weblink:
https://www.kuickresearch.com/report-Japan-Generics-Drug-Market-Outlook-2020.php
For Report Sample Contact: neeraj@kuickresearch.com
Table of Contents
1. Introduction to…
Sterile Injectables: Opportunities Galore for Generics Manufacturers
Increasing use of biologics in healthcare industry, with the gaining prominence, the emergence of antibody-drug conjugates (ADCs) and monoclonal antibodies (MA) into the drug development and clinical pipeline, has spurred growth of the sterile injectable market worldwide. According to Piramal, the development and manufacturing of sterile injectables is highly complex and capital intensive. The operative cost for injectable is high as almost all injectables in present pharma market are toxic…
Animal Pharm: Generics
ReportsWorldwide has announced the addition of a new report title Animal Pharm: Generics to its growing collection of premium market research reports.
In 2015, the global animal health market was worth an estimated $30bn. This new thoroughly revised and updated Animal Pharm Generics report focuses primarily on the European and North American markets that comprise around 67% of the global market for animal health products. Also fully reviewed are the EU…
Japan Generics Drug Market Japan Generics Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Japan Generic Drug Market
1.1 Reasons for Growth of Japan Generic Market
1.2 Some Misconceptions Related to Generic Drugs in Japan
2. Attractiveness of Japan Generic Market
2.1 Overview of Japan Pharmaceutical Market
2.2 Features of Japan Generic Drugs Market
2.3 Generic Drug Firms in Japan
2.4 Generic Drugs Import in Japan
…
Japan Generics Drug Market Outlook 2020
Japan is a small island nation located in East Asia and it is known for its economic prosperity. It sports one of the largest pharmaceutical markets like US and Europe due to which immense commercialization opportunities are present. Unique demographic structure and presence of advanced technology is the main reason for the growth of Japanese pharmaceutical industry. They have one of the most advanced research and development facilities across the…
US Cancer Generics Market Outlook 2022
“US Cancer Generics Market Outlook 2022” report gives comprehensive insight on the various indicators and trend analysis related to the emergence and integration of cancer generics drugs in mainstream pharmaceutical market in US. The report analyzes various clinical and non-clinical parameters responsible for the growth on cancer generics drugs in recent years. The introduction of generics has resulted in saving of billions of dollars for various stake holders involved US…
